Square Pharmaceuticals PLC. (DSE: SQURPHARMA)
Health Care · Pharmaceuticals · BD
Tk217.10
-0.55% today · +2.0% 1Y
Square Pharmaceuticals PLC. (DSE: SQURPHARMA) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.56B.
Over the last twelve months the share price has gained 2.0%, trading between 198.00 and 236.00.
Tweenvest scores Square Pharmaceuticals PLC. across four factors: quality 91/100, value 88/100, growth 36/100, dividend 98/100. Its strongest factor is dividend.
SQURPHARMA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.56B
- Revenue (TTM)
- $681.13M
- P/E
- 7.44
- EPS
- 29.18
- Dividend yield
- 5.53%
- Beta (5Y)
- 0.11
- 52-week high
- Tk236.00
- 52-week low
- Tk198.00
- Avg volume (3M)
- —
- Shares outstanding
- 886.45M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Sopharma ADBUL: SFA | $1.58B | €2.62 | -0.38% |
| Eton Pharmaceuticals, Inc.NasdaqGM: ETON | $1.58B | $55.76 | +1.00% |
| Mezzion Pharma Co.,Ltd.KOSDAQ: A140410 | $1.57B | ₩69,000.00 | +1.47% |
| Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.SZSE: 300357 | $1.56B | CN¥19.99 | -1.67% |
| Phibro Animal Health CorporationNasdaqGM: PAHC | $1.56B | $37.75 | -1.44% |
| North China Pharmaceutical Company.LtdSHSE: 600812 | $1.54B | CN¥6.03 | +21.08% |
| Innoviva, Inc.NasdaqGS: INVA | $1.53B | $21.46 | +1.18% |
| Jubilant Pharmova LimitedBSE: 530019 | $1.52B | Rs931.20 | -6.94% |
Figures last refreshed Oct 11, 2026.